Acquisition of cytogenetic abnormalities in patients with IPSS defined lower-risk myelodysplastic syndrome is associated with poor prognosis and transformation to acute myelogenous leukemia.
about
Myelodysplastic syndromes: 2015 Update on diagnosis, risk-stratification and managementClinical and genetic predictors of prognosis in myelodysplastic syndromes.Influence of Prognostic Factors on OverallSurvival in Myelodysplastic Syndromes.Rare cytogenetic abnormalities in myelodysplastic syndromes.Atg3 Overexpression Enhances Bortezomib-Induced Cell Death in SKM-1 CellDetectable FLT3-ITD or RAS mutation at the time of transformation from MDS to AML predicts for very poor outcomesJumping Translocations in Myeloid Malignancies Associated With Treatment Resistance and Poor Survival.Myelodysplastic syndromes: 2014 update on diagnosis, risk-stratification, and management.Molecular mechanisms of the progression of myelodysplastic syndrome to secondary acute myeloid leukaemia and implication for therapy.Cytogenetic clonal evolution in myelodysplastic syndromes is associated with inferior prognosis.Time-dependent changes in mortality and transformation risk in MDS.Impact of achievement of complete cytogenetic response on outcome in patients with myelodysplastic syndromes treated with hypomethylating agents.Frequency of del(12p) is commonly underestimated in myelodysplastic syndromes: Results from a German diagnostic study in comparison with an international control group.Myelodysplastic syndromes following therapy with hypomethylating agents (HMAs): development of acute erythroleukemia may not influence assessment of treatment response.Prognostic impact of acquisition of cytogenetic abnormalities during the course of chronic myelomonocytic leukemia.Identification of miRNA-mRNA Network Associated with Acute Myeloid Leukemia SurvivalKaryotype evolution and acquisition of FLT3 or RAS pathway alterations drive progression of myelodysplastic syndrome to acute myeloid leukemia.Characteristics and clinical significance of cytogenetic abnormalities in polycythemia vera.Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions.Myelodysplastic syndromes: 2018 update on diagnosis, risk-stratification and management.Detailed analysis of clonal evolution and cytogenetic evolution patterns in patients with myelodysplastic syndromes (MDS) and related myeloid disorders.
P2860
Q26796240-0BDA9772-6123-4A74-A63E-97627317974EQ33695906-E39322E5-E55F-4640-AFEB-607B8C410EB7Q34748960-716FC4B0-72A2-4A55-8F4F-EDDDBE42BF60Q35565387-C1E3FBC9-39CF-403E-B9EA-C61F7E167873Q36070978-37FA9C92-DF17-44C8-9792-EC3EF6B7BC17Q36770211-9C81F030-B8E6-4293-A670-A49DC5F72C12Q36816733-B1850598-9A84-4737-8D7F-8D1BC2313C9AQ38181996-F213EB14-4C96-4D93-871A-A2DF011AADA8Q38415206-264D2B29-8A92-46F3-8DE9-C9CD7F9BB9BFQ38659921-15B17086-B79C-42B1-9DE5-1138149F91FCQ39661429-B6734C47-415F-482C-BC58-D0C39607AB9FQ40385613-6EAADA2D-02A0-4708-9857-CDAC655B9CD4Q40555529-07114F47-616C-4B8E-8AA6-AEDF17F914C9Q41465409-DDDFCF7E-D551-48FC-ADE6-DBEFB683B5CFQ41609451-470B536F-29A5-4EDB-A6DF-11565FBBD1B8Q42267035-96A9CBB3-5843-4973-A02E-BD5F19A247D6Q43146967-5530FED3-C57E-4D38-B0A2-32CB4F442135Q45332610-48979AAD-C553-4395-B98F-695CD0A764A1Q47124670-61C9452A-D9CD-4BAF-8ACC-56F74EA309C0Q47548041-FD262229-D3BF-4706-A60C-3A8DE07AEEB3Q52668587-34D6688D-E0E3-4B87-9A23-018CA855DA17
P2860
Acquisition of cytogenetic abnormalities in patients with IPSS defined lower-risk myelodysplastic syndrome is associated with poor prognosis and transformation to acute myelogenous leukemia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Acquisition of cytogenetic abn ...... to acute myelogenous leukemia.
@en
Acquisition of cytogenetic abn ...... to acute myelogenous leukemia.
@nl
type
label
Acquisition of cytogenetic abn ...... to acute myelogenous leukemia.
@en
Acquisition of cytogenetic abn ...... to acute myelogenous leukemia.
@nl
prefLabel
Acquisition of cytogenetic abn ...... to acute myelogenous leukemia.
@en
Acquisition of cytogenetic abn ...... to acute myelogenous leukemia.
@nl
P2093
P2860
P50
P356
P1476
Acquisition of cytogenetic abn ...... to acute myelogenous leukemia.
@en
P2093
A Megan Cornelison
Francisco Sole
Koichi Takahashi
Lynne Abruzzo
Xuemei Wang
P2860
P304
P356
10.1002/AJH.23513
P50
P577
2013-07-23T00:00:00Z